ANNUAL GENERAL MEETING of the Heart Failure Society of South Africa
Dec 3, 2019
ANNUAL GENERAL MEETING of the Heart Failure Society of South Africa
3 November 2019 Sandton CC, Sandton 07.00 – 08.15
1. Welcome by President
a) Quorum not present (signed Attendance Register available from HeFSSA office)
To officiate the minutes, HeFSSA constitution states that:
“In the absence of a quorum the Executive committee shall have the power to convene another Annual General Meeting, at which any number of members shall constitute a quorum, within a period of not less than 48 hours. Decisions shall be reached by majority of votes present.”
Skype Exco meeting to be arranged latest January 2020 (and serve as AGM)
b) Apologies received: Prof Makoali Makotoko, Dr Nqoba Tsabedze, Prof Mpiko Ntsekhe, Prof Nash Ranjith, Dr Tony Lachman, Dr Len Steingo, Prof Karen Sliwa,
c) Attendees: Martin Mpe, Eric Klug, Ntobeko Ntusi, Jens Hitzeroth, Blanche Cupido, Sajidah Khan, Darryl Smith, Wan Zhu Zhang, Farai Dube, Jacob Koshy, George Nel, Joh-Ann Nice, Wihan Scholtz
d) Proxies appointed: Dr. Martin Mpe for Dr Nqoba Tsabedze; Dr. Blanche Cupido for Prof Mpiko Ntsekhe,
2. Presidents review:
a) Committee Members:
Martin Mpe (President), Eric Klug (Ex-Officio President), Jens Hitzeroth (Vice-President), Darryl Smith (Treasurer), Nash Ranjith (Secretary) and Karen Sliwa, Tony Lachman, Makoali Makotoko, Nqoba Tsabedze, Ntobeko Ntusi and Mpiko Ntsekhe. The committee will stand until 2020.
Dr Mpe indicated that he will not be available to stand for another term as President and need to elect a new President at AGM 2020.
Len Steingo – offered his resignation as of AGM 2019 which was accepted with gratitude for his contribution other many years.
b) The HeFSSA GP Program 2019
i. Case presentations:
- Refractory oedema in heart failure patient
- Management of acute decompensated heart failure
- Heart failure during pregnancy
- Dyspnoea and leg swelling, when is it heart failure
Prof Ntobeko Ntusi
Dr Nqoba Tsabedze
Prof Karen Sliwa
Dr Jens Hitzeroth
ii. Thank you to Profs Ntusi and Sliwa and Drs Tsabedze and Hitzeroth for the preparation of the slide sets. Received very positive feedback overall on the complexity (level) and quality of the slide sets from faculty and delegates.
iii. Dr Mpe had gone through the slide sets only to remove duplications and thank the case preparers for their incredible contribution.
iv. 702 delegates (GP, Fellows, Medical Advisors) attended the 15 meetings with 28 faculty members in RSA and 5 in Namibia. 5 Meetings still to take place, with an estimated attendance of 230. Estimated close on 1,000 Delegates for 2019 program (vs 550 delegates in 2018)
v. Total of 20 Workshops across SA, of which 3 workshops are HeFSSA Sponsored (partnering with industry in these regions to assist with the meeting).
DG at DoH resigned but endorsed the GP Program before term ended.
MM engaged with the National DoH for Entresto to be included on the EDL.
There are three positions available for SA Heart under the NCD portfolio, awaiting the call for nominations. HeFSSA (and SA Heart) needs an agenda on when specific input will be required from the societies, so the committee members can put time aside to contribute effectively.
HeFSSA Office actively engaged with DoH to ensure distribution of GP Workshop invitations.
Blanche Cupido - Developing Heart Failure Program for primary care givers in Cape Town (basic guideline development and educational program). HeFSSA will support this initiative in 2020 with resources and fundin
c) Cardio Update for
i. Well attended of more than 170 delegates
ii. Take note “not to consider” faculty who “cancel” on the day (Dr Mpe had to step in to present for a no show)
iii. Overall very positive feedback, delegates were especially excited about the program
iv. Thank you to Len Steingo and Nqoba Tsabedze for putting the workshop together.
Note - Need to confirm if Drs Steingo and Tsabedze will be willing to represent HeFSSA as conveners for the 2020 Cardio Update meeting.
v. Sponsorship received from Boehringer Ingelheim, Novartis & Servier. Pfizer had also contributed to the sponsorship, but as this was done through their medical, with no recognition given (as per Pfizer internal compliance).
d) HeFSSA Travel Award 2019
i. The following delegates received sponsorship to attend AfricaPCR:
Prof Makoali Makotoko (Bloemfontein)
Dr Mark Willoughby (Cape Town)
Dr Sharen Maharaj (Durban)
Dr Jithan Jacob Koshy (PE)
Dr Nitien Hira Naran (Johannesburg)
Dr Martin Mpe (Pretoria)
ii. Prof Makotoko could unfortunately not attend because of medical reasons – Suggested that unit should be asked to nominate a replacement if possible (time dependent)
iii. Dr Klug proposed that sponsored delegates should be “requested” to attend the AGM, as part of their obligations for the grant received (and hopefully contribute to the society)
Thank you to corporate supporters: Boston Scientific, Medtronic, Pharma Dynamics, Servier, Vertice,
Biotronik, Pfizer and Novartis.
3. Annual Financial Statements
a) HeFSSA VAT registered Jan 2019 and Received Tax Exemption
b) Cash on Hand end Dec 2018 R 2,250 million with retained income of R 275k.
c) More than 85% of income is spend on educational activities (under special programs)
d) Approve of the annual financial statements and the director report for the Year End 31 December 2018
e) Reappointment of Christoff Viljoen Registered Accountants and Auditors for the following year
Proposed – Eric Klug Second – Jens Hitzeroth
4. Items for discussion
a) ESC 2016 HF Guidelines
i. Dr Hitzeroth to add “new information” (FLOW trial) and circulate by end Jan 2020.
ii. Sylvia Dennis (@ Karen Sliwa) can assist with the final editing and preparation for submission.
iii. Guidelines to be submitted to SA Heart Journal and SAMJ (by end Q1 2020)
b) Engagement with DOH on EDL, Guidelines and Training
i. HeFSSA actively engaged with DoH to ensure distribution of GP Workshop invitations to regional offices.
ii. DoH is focusing on growing their involvement with the HF GP Workshops in 2020.
iii. MM suggested that guidelines be very specific and descriptive, to include primary care givers.
iv. DoH requested a measurement of the impact of the programs.
v. 2017 evaluations indicated that 1 of 2 attendees are retained from prior years
i. HF Academy – proposed by Novartis based on International program that Nqoba Tsabedze was involved in. Dr Cupido to engage with ESC on their content and modules available (8 modules covered over 2 years). Dr Blanche to discuss with Dr Nqoba on developing content.
ii. GP HF Workshop Theme 2020 – MM to confirm
iii. Cardio Update for Non-Cardio’s 2020 – Conveners to be confirmed
iv. SA Heart Congress 2020 (stand over)
v. Specialist Treatment and HF Device Therapy Course for 2020
a. Industry interest in sponsoring a workshop – Need to be re-engaged.
b. Nqoba Tsabedze had a draft program for 2019 and will be used as base.
c. HeFSSA can provide seeding funding to allow engagement of international faculty and to secure suitable venue. Industry to be engaged to provide additional support and travel grants through HeFSSA.
d) SHARE Modules such as HF Device Module [with CASSA]
i. Eric Klug reported that he will meet with E Schaafsma before year end to rekindle the development
e) Snapshot Survey of HF Market 2020 [burden of disease]
i. Prof Makotoko was not present at the AGM to report on progress
ii. W Scholtz (Medsoc Group) has been allocated the project and will support going forward.
iii. Protocol and paperwork should be prepared by end of 2019.
iv. Univ Free State ethics will be sought and should form basis for other ethics applications.
v. Pharma Ethics to be engaged for private sector approval
vi. Survey will run during World Heart Day – 29 September 2020 (might consider early trial run)
5. New Items Tabled – None
6. Close with Thanks by President